Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.21.1
Shareholders' Deficit (Tables)
 3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of activity related to non-vested shares
Number of
Non-vested
Shares		 Weighted
Average
Grant Date
Fair Value
Non-vested, December 31, 2020 23,826,926 $ 0.16
Granted 5,194,767 0.07
Shares vested (7,993,140 ) (0.12 )
Non-vested, March 31, 2021 21,028,553 $ 0.16
Schedule of stock option activities
Number of Options Weighted Average
Exercise Price 		Weighted
Average
Remaining
Contractual
Term (Years) 		Aggregate
Intrinsic Value
Balance Outstanding, December 31, 2020 8,445,698 $ 0.40 5.10 $ 48,000
Granted - - - -
Forfeited - - - -
Balance Outstanding, March 31, 2021 8,445,698 $ 0.40 4.92 $ 17,400
Exercisable, March 31, 2021 8,445,698 $ 0.40 4.92 $ 17,400
Schedule of warrant activities
Number of Warrants Weighted Average
Exercise Price 		Weighted
Average
Remaining
Contractual
Term (Years) 		Aggregate
Intrinsic Value
Balance Outstanding December 31, 2020 2,050,000 $ 0.05 3.66 $ 137,000
Exercised (1,050,000 ) 0.01 - -
Cancelled - - - -
Balance Outstanding March 31, 2021 1,000,000 $ 0.09 3.31 $ 1,800
Exercisable, March 31, 2021 1,000,000 $ 0.09 3.31 $ 1,800